ClouDr Group Ltd
Company Profile
Business description
ClouDr Group Ltd provides supplies and SaaS to hospitals and pharmacies, digital marketing services to pharmaceutical companies, and online consultation and prescriptions to patients, all centered around chronic condition management. The company’s in-hospital solution consists of sales of medical devices, consumables and pharmaceuticals, hospital SaaS, and digital marketing services to pharmaceutical companies, and out-of-hospital solution connects doctors and patients, and provides high-quality and trustworthy medical services through AI vertical model ClouD GPT. The company generates revenues from sales of hospital and pharmacy supplies and individual chronic condition management products.
Contact
No. 998 Wenyi West Road (Haichuang Yuan), Wuchang Street
Rooms 501, 5th Floor, Building 12
Yuhang District
Zhejiang Province
Hangzhou
CHNSector
Healthcare
Stock type
Defensive
Industry
Medical Distribution
Fiscal Year End
31 December 2026
Employees
966
Stocks News & Analysis
stocks
AI isn’t an economic moat killer, but it will disrupt industries
stocks
AI lands a blow on some Aussie stocks – yet stands to benefit others
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,552.60 | 77.00 | 0.91% |
| CAC 40 | 7,726.20 | 60.58 | 0.79% |
| DAX 40 | 22,653.86 | 273.67 | 1.22% |
| Dow JONES (US) | 46,282.04 | 704.57 | 1.55% |
| FTSE 100 | 9,894.15 | 24.18 | -0.24% |
| HKSE | 24,382.47 | 894.85 | -3.54% |
| NASDAQ | 21,982.47 | 334.86 | 1.55% |
| Nikkei 225 | 51,515.49 | 1,857.04 | -3.48% |
| NZX 50 Index | 12,899.72 | 90.27 | -0.69% |
| S&P 500 | 6,592.78 | 86.30 | 1.33% |
| S&P/ASX 200 | 8,365.90 | 82.40 | 0.99% |
| SSE Composite Index | 3,813.28 | 143.77 | -3.63% |